Fact-checked by Grok 2 weeks ago

Troponin T

Troponin T (TnT) is a regulatory protein that forms one of three subunits of the troponin complex in striated muscle fibers, alongside troponin I and troponin C. It binds to tropomyosin on the thin filaments of the sarcomere, anchoring the troponin complex and enabling calcium-dependent regulation of muscle contraction by modulating actomyosin ATPase activity.^[1] Three genes encode tissue-specific isoforms of TnT: TNNT1 for slow skeletal muscle, TNNT2 for cardiac muscle, and TNNT3 for fast skeletal muscle. These isoforms differ in structure and expression patterns, adapting to developmental stages, aging, and physiological needs, with molecular weights typically ranging from 30 to 35 kDa.^[2] In clinical practice, cardiac TnT (cTnT), the isoform from TNNT2, is a key biomarker for detecting myocardial injury, such as in acute myocardial infarction, where elevated serum levels indicate cardiomyocyte damage.^[3]

Overview

Definition and Discovery

Troponin T (TnT) is a 37-kDa protein subunit of the troponin complex, which plays a crucial role in the calcium-dependent regulation of striated muscle contraction. It specifically binds to tropomyosin, anchoring the troponin complex to the thin filament composed primarily of actin, thereby facilitating the precise control of actin-myosin interactions essential for muscle contraction.^[4]^[5] The discovery of troponin, including its TnT component, traces back to the pioneering work of Setsuro Ebashi and his collaborators in Japan during the 1960s. Ebashi first identified troponin as a calcium-binding protein in skeletal muscle in 1963, revealing its role in regulating contraction. By 1971, Michael L. Greaser and Julius Gergely demonstrated that the troponin complex comprises three distinct subunits, which they designated TnC (calcium-binding), TnI (inhibitory), and TnT (tropomyosin-binding). Ebashi's group further advanced this in 1973 by isolating and characterizing cardiac troponin, confirming TnT's presence and function in heart muscle.^[6]^[7]^[8] In the 1980s, Hugo A. Katus at the University of Heidelberg developed the first cardiac-specific immunoassay for TnT, enabling its detection in serum as a biomarker for myocardial injury; this assay, introduced in 1989, revolutionized clinical diagnostics by providing high specificity for cardiac damage.^[9]^[10] Evolutionarily, TnT originated from ancient actin-binding proteins present in bilaterian ancestors around 700 million years ago, undergoing diversification through whole-genome duplications in early vertebrates to support specialized muscle regulation. This evolutionary adaptation allowed TnT to integrate with the troponin complex, enabling calcium-sensitive control of contraction in vertebrate striated muscles.^[11]

Role in the Troponin Complex

The troponin complex is a heterotrimeric protein assembly consisting of troponin T (TnT), troponin I (TnI), and troponin C (TnC), which collectively regulate muscle contraction by modulating interactions between actin and myosin filaments. TnT serves as the tropomyosin-binding subunit, while TnI acts as the inhibitory component that prevents actin-myosin binding in the absence of calcium, and TnC functions as the calcium-binding subunit that initiates conformational changes upon calcium ion binding. This complex associates with the actin-tropomyosin thin filament in striated muscle, enabling precise control of contraction through calcium signaling.^[1]^[12] TnT plays a critical structural role by anchoring the troponin complex to the thin filament via its binding to tropomyosin, a coiled-coil protein that spans seven actin monomers along the filament. This interaction, primarily mediated by the middle and C-terminal domains of TnT, stabilizes the positioning of the entire complex and ensures its periodic distribution every 38 nm along the actin filament, aligning with tropomyosin repeats. By securing TnI and TnC in proximity to actin, TnT facilitates the transduction of calcium signals from TnC to alter tropomyosin's position, thereby exposing or blocking myosin-binding sites on actin as needed for contraction or relaxation.^[1]^[12]^[13] The troponin complex, including TnT, is predominantly expressed in striated muscles, such as cardiac and skeletal types, where it is essential for calcium-dependent regulation of contraction. Cardiac TnT is specific to heart tissue, while skeletal isoforms vary between fast- and slow-twitch fibers, reflecting adaptations to different contractile demands. In contrast, the complex is absent in smooth muscle, which relies on alternative regulatory mechanisms involving calmodulin and myosin light chain phosphorylation rather than troponin-mediated control.^[1]^[12]^[14]

Molecular Structure and Interactions

Protein Domains and Composition

Troponin T (TnT) in human cardiac muscle is a polypeptide comprising 288 amino acids (287 residues after removal of the initiating methionine), with a molecular weight of approximately 36 kDa.^[1] The protein is predominantly composed of alpha-helical segments that form elongated, rod-like coiled-coil structures, enabling its integration into the thin filament architecture of striated muscle.^[1] The primary structure of cardiac TnT is organized into three key domains. The N-terminal domain (residues 1–70) is a hypervariable region that exhibits isoform-specific sequence variations and does not directly bind other contractile proteins, contributing to tissue-specific regulatory properties.^[15] The central domain (residues 70–180), often referred to as the tropomyosin-binding domain, features conserved alpha-helical motifs that facilitate anchoring to tropomyosin along the thin filament.^[16] The C-terminal domain (residues 200–288) serves as the primary interface for binding troponin I and troponin C, forming the core of the troponin complex through additional helical elements.^[1] Post-translational modifications of TnT are limited but functionally significant, primarily involving phosphorylation at multiple serine residues in the N-terminal domain, which modulates myocardial contractility by influencing calcium sensitivity.^[17] Unlike some other myofibrillar proteins, TnT lacks N-linked glycosylation sites.^[18] Structural studies, including X-ray crystallography and NMR spectroscopy, reveal an overall elongated conformation for TnT fragments, with the C-terminal region adopting a compact globular fold in complex with other troponin subunits; for instance, the crystal structure of the skeletal muscle troponin core domain (PDB ID: 1YV0) highlights the alpha-helical organization in the calcium-free state, providing insights applicable to the cardiac isoform.^[19]

Binding Partners and Interactions

Troponin T (TnT) primarily binds with high affinity to tropomyosin (Tm) through its central domain, characterized by electrostatic interactions involving salt bridges that stabilize the troponin-tropomyosin complex on the thin filament.^[20] This binding exhibits a dissociation constant (Kd) of approximately 20 nM, underscoring its strong association essential for anchoring the troponin complex.^[20] In contrast, TnT forms weaker interactions with troponin I (TnI) and troponin C (TnC), primarily via its C-terminal domain, which facilitates the assembly of the heterotrimeric troponin complex but with lower binding strength compared to Tm.^[13] These interactions are dynamic within the sarcomere, where the TnT-Tm association positions the troponin complex to block myosin-binding sites on actin during muscle relaxation, thereby inhibiting cross-bridge formation.^[21] Upon activation, this configuration shifts, allowing TnT-mediated repositioning of Tm to expose actin sites for myosin interaction.^[21] Pathological mutations in TnT, such as those associated with hypertrophic cardiomyopathy, often disrupt these binding affinities; for instance, certain variants reduce TnT's interaction with TnI by at least sixfold or alter Tm binding, leading to dysregulated thin filament dynamics.^[22] In skeletal muscle, TnT also interacts with thin filament proteins like nebulin through shared motifs on Tm and TnT, which help stabilize filament length and structure.^[23] Experimental evidence from co-immunoprecipitation assays confirms the cooperative nature of TnT-Tm binding, even in the absence of actin, highlighting multiple interaction sites that enhance complex stability.^[24] Additionally, Förster resonance energy transfer (FRET) studies have mapped TnT's linker region and interfaces, revealing conformational changes that underpin these molecular partnerships during filament regulation.^[25]

Isoforms and Genetics

Subtypes and Isoforms

Troponin T (TnT) is expressed as tissue-specific isoforms encoded by three distinct genes in vertebrates: TNNT1 for slow skeletal muscle TnT (sTnT), TNNT3 for fast skeletal muscle TnT (fTnT), and TNNT2 for cardiac TnT (cTnT).^[26] These isoforms differ in their primary structures, particularly in the N-terminal variable region, which influences their interactions within the troponin complex.^[2] The cardiac isoform, cTnT, is encoded by the TNNT2 gene and represents the single predominant form in the adult heart, with near 100% tissue-specific expression in cardiac muscle.^[27] In skeletal muscle, sTnT (TNNT1) predominates in slow-twitch fibers, supporting endurance-oriented contraction, while fTnT (TNNT3) is expressed in fast-twitch fibers, facilitating high ATPase activity for rapid force generation.^[2] Neonatal skeletal muscle initially expresses transitional isoforms, including a high-molecular-weight acidic fTnT variant, which shifts postnatally to the adult basic form; concurrently, embryonic cTnT expression in skeletal muscle ceases after birth.^[2] Developmental isoforms exhibit distinct splicing patterns; for instance, fetal cardiac TnT includes an additional 9-10 amino acids from exon 5, which is excluded in the adult isoform through alternative splicing shortly after birth.^[2] In human cardiac tissue, four cTnT variants arise from alternative splicing, but the adult-specific isoform (cTnT3) becomes dominant postnatally, while fetal forms (cTnT1 and cTnT4) predominate early in development.^[27]

Gene Structure and Mutations

The TNNT2 gene, which encodes the cardiac isoform of troponin T, is located on the long arm of human chromosome 1 at position 1q32.1 and spans approximately 17 kb, consisting of 17 exons.^[28] The TNNT1 gene, encoding the slow skeletal muscle isoform, resides on chromosome 19q13.42 and comprises 15 exons.^[29] In contrast, the TNNT3 gene, responsible for the fast skeletal muscle isoform, is situated on chromosome 11p15.5.^[30] Transcription of the TNNT genes is regulated by muscle-specific promoters responsive to key transcription factors, including myocyte enhancer factor 2 (MEF2) and serum response factor (SRF), which drive expression in cardiac and skeletal muscle cells.^[31] Alternative splicing of TNNT transcripts, particularly in the N-terminal region, generates multiple isoforms that contribute to tissue-specific and developmental variations in troponin T function.^[2] Mutations in TNNT2 are a significant cause of inherited cardiomyopathies, with over 30 distinct pathogenic variants identified, predominantly missense mutations linked to hypertrophic cardiomyopathy (HCM).^[32] These mutations account for approximately 5% of familial HCM cases and typically follow an autosomal dominant inheritance pattern.^[33] For instance, the Arg92Gln missense mutation in TNNT2 increases myofilament calcium sensitivity, contributing to HCM pathogenesis.^[34] In dilated cardiomyopathy, variants such as the Lys210 deletion (Lys210del) in exon 13 have been associated with disease severity, also inherited in an autosomal dominant manner.^[35] Mutations in the skeletal isoforms are rarer; in TNNT1, several variants cause nemaline myopathy, a congenital muscle disorder characterized by muscle weakness and nemaline rod formation in myofibers, with autosomal recessive or dominant inheritance depending on the specific mutation.^[36] A notable example is the founder mutation c.505G>T (p.Glu169Ter) in exon 11 of TNNT1, prevalent in Amish populations and leading to a severe, early-onset form of the myopathy.^[36] TNNT3 mutations are infrequently reported but can result in distal arthrogryposis or other skeletal myopathies through autosomal dominant mechanisms.^[30]

Function in Muscle Contraction

Mechanism of Action

Troponin T (TnT) integrates into the sliding filament theory by anchoring the troponin complex to tropomyosin along the actin thin filaments of the sarcomere, positioning tropomyosin in a relaxed state to sterically block myosin head binding sites on actin. In the absence of calcium, TnT's C-terminal domain stabilizes tropomyosin in the blocked (B-state) position on actin's outer domain (subdomains 1 and 2), preventing cross-bridge formation between actin and myosin thick filaments and maintaining muscle relaxation. This inhibitory configuration ensures that the thin filaments remain inaccessible to myosin until regulatory signals initiate contraction.^[37] The activation sequence begins when calcium ions bind to troponin C (TnC), inducing a conformational change that releases the inhibitory interaction of troponin I (TnI) with actin. TnI's C-terminal region, previously bound to actin in the low-calcium state, dissociates, allowing TnT to facilitate the repositioning of tropomyosin toward the closed (C-state) on actin's inner domain (subdomains 3 and 4). This shift exposes myosin-binding sites on actin, enabling myosin heads to form cross-bridges, undergo power strokes, and slide the thin filaments past the thick filaments during contraction. TnT's role in this process involves its elongated structure bridging the troponin core to tropomyosin, propagating the calcium signal along the thin filament for coordinated activation.^[37]^[38] TnT further modulates thin filament cooperativity by enhancing the allosteric communication between regulatory units, where activation at one site promotes neighboring sites to adopt the open state, amplifying force generation across the sarcomere. This cooperative effect increases the efficiency of cross-bridge cycling and, in fast skeletal muscle isoforms of TnT, elevates contraction velocity without altering maximum force output. For instance, expression of fast skeletal TnT in cardiac muscle raises the Hill coefficient of calcium activation from approximately 1.0 to 2.0, indicating heightened cooperativity.^[39]^[40] TnT possesses no direct ATPase activity but indirectly influences myosin-ATP hydrolysis by controlling the exposure of actin sites, thereby regulating the rate at which myosin cross-bridges hydrolyze ATP to generate force during the sliding filament mechanism. In the relaxed state, TnT-tropomyosin inhibition prevents myosin binding and subsequent ATP utilization, conserving energy; upon activation, filament exposure accelerates hydrolysis rates without altering the intrinsic kinetics of the ATPase cycle itself.^[41]

Calcium-Dependent Regulation

Troponin C (TnC) within the troponin complex acts as the primary calcium sensor, binding four Ca²⁺ ions across two high-affinity sites (III and IV, with dissociation constants Kd ≈ 10⁻⁸–10⁻⁹ M) that maintain structural integrity and two low-affinity regulatory sites (I and II, Kd ≈ 10⁻⁶ M). Binding to the low-affinity sites induces a conformational opening in TnC's N-terminal domain, releasing the inhibitory peptide of troponin I (TnI) and propagating allosteric changes through troponin T (TnT) to tropomyosin. TnT serves as the scaffold that anchors the complex to tropomyosin and transmits the calcium signal, enabling the repositioning of tropomyosin along the actin filament to expose myosin-binding sites.^[42]^[43] Upon Ca²⁺ saturation of TnC, TnT undergoes targeted conformational shifts, particularly in its C-terminal domain, which interacts directly with tropomyosin. This opening of TnT's C-domain facilitates an azimuthal movement of tropomyosin by approximately 10 Å from its blocked position, transitioning the thin filament to a configuration that permits cross-bridge attachment to actin. The signal transmission via TnT's tropomyosin-binding motifs ensures coordinated regulation across the thin filament, with cryo-EM studies revealing TnT's rotation by ~30° to accommodate this shift.^[44]^[45] Myofilament Ca²⁺ sensitivity is modulated by post-translational modifications and isoform variations in TnT. Phosphorylation at the N-terminal region of cardiac TnT (e.g., at serine residues) reduces Ca²⁺ sensitivity of force generation and ATPase activity, facilitating faster relaxation by decreasing TnT's affinity for tropomyosin and promoting thin filament deactivation. Isoform-specific differences further tune this regulation; for instance, skeletal TnT confers higher Ca²⁺ sensitivity compared to cardiac TnT, supporting distinct contraction-relaxation kinetics between muscle types.^[46]^[47] Stopped-flow fluorescence spectroscopy experiments demonstrate the rapidity of Ca²⁺-induced activation in the troponin complex, with conformational changes and tropomyosin repositioning occurring on the millisecond timescale following Ca²⁺ binding to TnC, underscoring TnT's role in efficient signal relay.^[48]

Clinical and Diagnostic Applications

Biomarker for Cardiac Injury

Cardiac troponin T (cTnT) is released into the bloodstream following injury to cardiomyocytes, primarily due to increased membrane permeability and subsequent leakage of intracellular contents, including the troponin complex bound to the sarcomere. This release is often accompanied by local proteolysis that dissociates cTnT from other components, allowing it to enter the interstitial space and circulation.^[49]^[50] The biological half-life of cTnT is approximately 2 hours, but due to ongoing release from damaged tissue, elevations can persist and be detectable for 7-10 days after acute injury.^[51]^[50] In clinical practice, elevated cTnT levels serve as a key biomarker for diagnosing acute myocardial infarction (AMI), with concentrations exceeding the 99th percentile upper reference limit of a healthy population indicating myocardial injury. This threshold, combined with evidence of ischemia such as symptoms, ECG changes, or imaging findings, fulfills the diagnostic criteria for AMI as outlined in the Fourth Universal Definition of Myocardial Infarction.^[52]^[53] Guidelines, including the 2018 Fourth Universal Definition of Myocardial Infarction and the 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes, emphasize serial measurements to detect dynamic changes, enhancing specificity for acute events.^[52]^[54] Beyond acute diagnosis, cTnT holds prognostic significance, particularly in chronic conditions. Persistently elevated levels in heart failure patients independently predict increased risks of all-cause mortality, cardiovascular death, and hospitalization, reflecting ongoing myocardial stress or subclinical injury.^[55] Recent studies, such as a 2023 post-hoc analysis of the SEAS trial, have linked high-sensitivity cTnT (hs-cTnT) levels above 14 ng/L in asymptomatic non-severe aortic stenosis to approximately doubled risk of adverse cardiovascular events, including the need for aortic valve replacement and mortality.^[56] Despite its utility, cTnT elevation is not entirely specific to AMI, leading to potential false positives in conditions like renal failure, where reduced clearance prolongs detectable levels, and sepsis, which can induce myocardial stress without infarction.^[57] Similarly, elevations occur in non-ischemic cardiac pathologies such as myocarditis and pulmonary embolism, necessitating clinical correlation to avoid misdiagnosis.^[58]^[59]

Reference Values and Assay Methods

Reference values for cardiac troponin T (cTnT) are established based on the 99th percentile upper reference limit (URL) in healthy populations, serving as the threshold for detecting myocardial injury. For high-sensitivity cTnT (hs-cTnT) assays, sex-specific cutoffs are recommended, with the upper limit typically set at less than 14 ng/L for women and less than 22 ng/L for men, reflecting lower baseline concentrations in females due to differences in cardiac mass and release kinetics.^[60] These values align with FDA-cleared assays and improve diagnostic accuracy by reducing overdiagnosis in women. Conventional cTnT assays, which have lower analytical sensitivity, use a cutoff of less than 0.01 ng/mL as the normal range, beyond which elevations indicate potential cardiac damage.^[61] Skeletal muscle isoforms of troponin T are not routinely measured in clinical settings, as commercial assays employ epitope-specific antibodies that minimize cross-reactivity with non-cardiac forms.^[62] Assay methods for cTnT primarily rely on immunoassays, which detect the protein through antigen-antibody interactions. The Roche Elecsys hs-cTnT assay, an electrochemiluminescence immunoassay, was the first high-sensitivity cTnT test approved by the FDA in 2017, enabling detection of concentrations as low as 3 ng/L with a broad dynamic range up to 10,000 ng/L. In 2025, Roche introduced the Elecsys Troponin T hs Gen 6 assay, which received CE Mark in September 2025 and provides enhanced analytical sensitivity and standardization for ACS diagnosis, though FDA approval is pending as of November 2025.^[63]^[64] These assays utilize pairs of monoclonal antibodies targeting unique epitopes on the cardiac-specific region of cTnT, such as the central tropomyosin-binding domain, to ensure high specificity and negligible cross-reactivity (less than 0.1%) with skeletal troponin T isoforms.^[65] Point-of-care (POC) assays, like lateral flow or handheld devices, provide rapid results (under 20 minutes) but generally offer lower precision compared to central laboratory methods, which use automated analyzers for higher throughput and sensitivity in serial monitoring.^[66] Serial sampling is essential for confirming acute myocardial injury, as a single elevated value may reflect chronic conditions. Guidelines emphasize evaluating the rise-and-fall pattern, where a change greater than 20% from baseline (or an absolute delta of at least 5-7 ng/L for hs-cTnT) between samples taken 1-3 hours apart distinguishes acute from stable elevations.^[67] This dynamic assessment enhances specificity, particularly in emergency settings, by confirming ongoing necrosis rather than baseline variability. Standardization efforts, led by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), promote harmonization across assays to ensure comparable results globally. The IFCC Working Group on Troponin I (extended to cTnT) provides reference materials and protocols for calibrating against certified standards, reducing inter-assay variability to under 10%.^[68] Sex-specific cutoffs gained formal endorsement in major guidelines around 2021, with the AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR 2021 chest pain protocol explicitly recommending their use for hs-cTnT to optimize rule-out strategies in suspected acute coronary syndrome.^[69]

References

[1]
Troponin structure and function: a view of recent progress - PMC
Apr 27, 2019 · Troponin I. Troponin I (TnI) is expressed in three different isoforms: cardiac, slow skeletal and fast skeletal muscle TnI.
[2]
Troponin T Isoforms and Posttranscriptional Modifications: Evolution ...
This review focuses on the structure-function relationship of troponin T, one of the three protein subunits of the troponin complex.
[3]
Troponin Structure and Function in Health and Disease
Oct 1, 2018 · Troponin-T TnT contains 3 distinct genes that produce 3 different protein isoforms: (1) TNNT1 for slow twitch skeletal muscle (ssTnT), (2) TNNT ...
[4]
Troponin T - an overview | ScienceDirect Topics
C Troponin. Troponin, originally isolated by Ebashi (Ebashi et al., 1968), is the other key regulatory protein in vertebrate skeletal muscle and ...
[5]
https://www.ptglab.com/products/TNNT2-Antibody-15513-1-AP.htm
[6]
Background to the discovery of troponin and Setsuro Ebashi's ...
Apr 25, 2008 · The report by Ebashi in 1963 that a new myofibrillar protein, troponin, was the target for calcium opened up the investigation of the calcium ...Missing: 1973 | Show results with:1973
[7]
Reconstitution of troponin activity from three protein components
Reconstitution of troponin activity from three protein components. J Biol Chem. 1971 Jul 10;246(13):4226-33. Authors. M L Greaser, J Gergely. PMID: 4253596. No ...
[8]
Cardiac Troponin - PubMed
Cardiac Troponin. J Biochem. 1973 May;73(5):1119-21. doi: 10.1093/oxfordjournals.jbchem.a130168. Authors. R Tsukui, S Ebashi.Missing: T group
[9]
Hugo Katus, MD | myadlm.org
After years of work in the field, in 1984 he was the first to develop a cardiac-specific troponin assay that demonstrated in initial clinical trials the ...Missing: 1980s | Show results with:1980s
[10]
An historical approach to the diagnostic biomarkers of acute ...
May 19, 2016 · In 1971, Greaser and Gergely demonstrated that the troponin complex actually consists of three components which were named TnC, TnI, and TnT on ...1971: Troponin Isoforms · 1987: Ctni Assays · 1989: Ctnt Assays
[11]
Revised Perspective on the Evolution of Troponin ... - Oxford Academic
Tn-Ca2+ binding induces a conformational change that moves tropomyosin and allows the formation of actin–myosin cross-bridges which generate contractile force.
[12]
Troponin Variants as Markers of Skeletal Muscle Health and Diseases
Sep 27, 2021 · Troponin T TnT is the Tm-binding subunit of troponin. It functions to anchor the troponin complex onto the thin filament as well as transduce ...
[13]
Troponin T is essential for sarcomere assembly in zebrafish skeletal ...
Troponin T anchors the complex to the thin filament by binding to tropomyosin. Following stimulation, calcium ions released from the sarcoplasmic reticulum ...
[14]
A review of troponins in ischemic heart disease and other conditions
Troponins are found in skeletal and cardiac muscle, but not in smooth muscle. Approximately 7% of cardiac TnT (cTnT) and 3.5% of cTnI exist freely in the ...
[15]
Gene regulation, alternative splicing, and posttranslational ...
Troponin T is a striated muscle-specific protein of ~250–305 amino acids with molecular weights ranging from 31-kDa to 36-kDa. Same as the differentiated TnI ...
[16]
Molecular mechanisms and structural features of cardiomyopathy ...
Oct 2, 2017 · Troponin T (TnT), encoded by TNNT2, harbors most of its pathogenic mutants at TNT1 (residues ∼80–180 of TnT). TNT1 is known to interact with ...
[17]
Phosphorylation, but not alternative splicing or proteolytic ... - PubMed
Jul 12, 2011 · Phosphorylation, but not alternative splicing or proteolytic degradation, is conserved in human and mouse cardiac troponin T. Biochemistry. ...Missing: no glycosylation
[18]
Troponin T, cardiac muscle - P45379 - UniProt
Jan 23, 2007 · Troponin T is the tropomyosin-binding subunit of troponin, the thin filament regulatory complex which confers calcium-sensitivity to striated muscle actomyosin ...<|control11|><|separator|>
[19]
1YVO: hypothetical acetyltransferase from P.aeruginosa PA01
Crystal structure of a hypothetical acetyltransferase from P.aeruginosa PA01 · Total Structure Weight: 37.9 kDa · Atom Count: 2,916 · Modeled Residue Count: 340 ...Missing: troponin T
[20]
Docking Troponin T onto the Tropomyosin Overlapping Domain of ...
Apr 27, 2019 · N-terminal regions of TnT1 are largely heli- cal, water soluble, and bind to tropomyosin with a high affinity (Kd $20 nM) (11,21,27,29–31).
[21]
Troponin T Core Structure and the Regulatory NH2-Terminal ...
The crystal structures of the partial cardiac and skeletal muscle Tn complex have revealed the molecular interactions that occur in the globular domain of Tn ( ...<|control11|><|separator|>
[22]
Regulatory domain of troponin moves dynamically during activation ...
At low [Ca2+], troponin docks on to the thin filament by binding of TnT to tropomyosin [4], [5] and the C-terminus of TnI (CTnI) to actin [6], [7].
[23]
Altered regulatory function of two familial hypertrophic ... - PubMed
Oct 5, 1999 · Both mutant troponin Ts have reduced affinity for troponin I; the shorter mutant is at least 6-fold weaker than wild-type. The low level of ...
[24]
Interactions between Nebulin-like Motifs and Thin Filament ...
Our data suggest that Tm and troponin T (TnT) both contain interaction sites for the nebulin-like motifs. These interactions were strengthened when Tm and TnT ...
[25]
Cooperative interaction between developmentally ... - PubMed
Aug 25, 2000 · Competition and co-immunoprecipitation experiments demonstrated that the binding of TnT to Tm was cooperative in the absence of F-actin. The ...Missing: studies | Show results with:studies
[26]
FRET-based analysis of the cardiac troponin T linker region reveals ...
Early proteolytic studies demonstrated that cTnT comprises two functional domains: the Tm-binding TNT1 domain and the calcium-sensitive TNT2 domain, which binds ...Missing: interfaces | Show results with:interfaces
[27]
TNNT1, TNNT2, and TNNT3: Isoform Genes, Regulation, and ...
While TNNT1 and TNNT3 are specifically expressed in slow and fast twitch skeletal muscle fibers, respectively, TNNT2 is expressed in cardiac muscle and ...
[28]
Molecular Basis of Human Cardiac Troponin T Isoforms Expressed ...
Cardiac troponin T (cTnT), a protein essential for calcium-regulated myofibrillar ATPase activity, is expressed in the human heart as four isoforms.
[29]
Selective Deletion of the NH2-Terminal Variable Region of Cardiac Troponin T in Ischemia Reperfusion by Myofibril-Associated μ-Calpain Cleavage†
### Summary of Troponin T Isoform Stability Differences Between Human and Rodent
[30]
Entry - *191045 - TROPONIN T2, CARDIAC; TNNT2 - (OMIM.ORG)
The troponin complex is located on the thin filament of striated muscle and is composed of 3 component polypeptides: troponin T (TNNT1, 191041; TNNT2), ...
[31]
TNNT1 troponin T1, slow skeletal type [ (human)] - NCBI
Sep 9, 2025 · This gene encodes a protein that is a subunit of troponin, which is a regulatory complex located on the thin filament of the sarcomere.Missing: structure chromosome
[32]
TNNT3 gene: MedlinePlus Genetics
Jun 1, 2015 · Genomic Location. The TNNT3 gene is found on chromosome 11. Related Health Topics. Genes and Gene Therapy · Genetic Disorders. MEDICAL ...
[33]
The Cardiac Transcription Network Modulated by Gata4, Mef2a ...
We present a systems biology study integrating mRNA profiles with DNA–binding events of key cardiac transcription factors (Gata4, Mef2a, Nkx2.5, and Srf), ...
[34]
Tale of two hearts: a TNNT2 hypertrophic cardiomyopathy case report
Apr 26, 2023 · Over 30 distinct pathogenic/likely pathogenic variants affecting TNNT2 gene products have been associated with HCM, with individual mutations ...Abstract · Introduction · Case presentation of patient B · Discussion
[35]
TNNT2 gene: MedlinePlus Genetics
Feb 1, 2013 · The TNNT2 gene provides instructions for making a protein called cardiac troponin T, which is found solely in the heart (cardiac) muscle.Missing: exons size<|separator|>
[36]
Expression of a Mutant (Arg92Gln) Human Cardiac Troponin T ...
Hypertrophic cardiomyopathy, a paradigm of cardiac hypertrophy and failure, is caused by mutations in genes coding for sarcomeric proteins. Thus far, mutations ...Missing: examples | Show results with:examples
[37]
Cardiac troponin T lysine 210 deletion in a family with dilated ...
Cardiac troponin T exon 13 lysine deletions can cause FDC of varying severity and are an important but uncommon cause of FDC.Missing: Lys210del | Show results with:Lys210del
[38]
TNNT1 nemaline myopathy: natural history and therapeutic frontier
The TNNT1 c.505G>T 'founder' mutation in exon 11 causes 'Amish' nemaline myopathy (ANM) by converting a glutamic acid codon to a premature stop codon ...
[39]
Structural Basis for the Activation of Muscle Contraction by Troponin ...
The precision with which tropomyosin is positioned is not simply a matter of troponin being present or absent, but rather also depends on the isoform of ...
[40]
Ca2+-regulated structural changes in troponin - PMC
Troponin senses Ca2+ to regulate contraction in striated muscle. Structures of skeletal muscle troponin composed of TnC (the sensor), TnI (the regulator), and
[41]
Fast skeletal muscle troponin T increases the cooperativity of ...
Cardiac muscle-specific expression of the fast skeletal muscle TnT has been obtained with significant myofibril incorporation. Expression of the endogenous ...
[42]
Thin Filament Cooperativity as a Major Determinant of Shortening ...
The present results therefore provide evidence that the thin filament cooperativity is primarily responsible for the calcium sensitivity of velocity. The effect ...
[43]
Inhibition of Actomyosin ATPase Activity by Troponin-Tropomyosin ...
Troponin-tropomyosin cannot inhibit the acto-S-1 ATPase activity by affecting the rate of the ATP hydrolysis step or the rate of transition from the refractory ...
[44]
Mechanism of the calcium-regulation of muscle contraction
Both of troponin and tropomyosin are essential for the calcium-regulation of striated muscle. Mutations of troponin or tropomyosin cause the familiar cardiac ...
[45]
The role of troponins in muscle contraction - PubMed - NIH
Troponin is a Ca2+ regulator that, by binding Ca2+, transmits information via structural changes, activating myosin ATPase and muscle contraction.
[46]
Cardiac muscle thin filament structures reveal calcium regulatory ...
Jan 9, 2020 · Muscle thin filament consists of actin, tropomyosin and troponin, and Ca2+ binding to troponin triggers conformational changes of troponin and ...Results · Protein Expression And... · Modeling Of Actin Filament...<|control11|><|separator|>
[47]
Crystal structure of troponin and the molecular mechanism of muscle ...
Troponin, with three chains, regulates muscle contraction. Calcium binding to TnC displaces TnI, altering troponin's flexibility and affecting myosin access.
[48]
Impact of Cardiac Troponin T N-Terminal Deletion and ...
These data are in agreement with our model that removal of N-terminal segment 1−91 lowers the affinity of cTnT to Tm and leads to a more flexible Tm-Tm end-to- ...Missing: text | Show results with:text
[49]
Differences between Cardiac and Skeletal Troponin Interaction with ...
Comparison of fast skeletal (s) and cardiac (c) muscle contraction as a function of calcium showed that skeletal muscle is slightly more calcium sensitive and ...
[50]
Calcium binding kinetics of troponin C strongly modulate ... - NIH
Stopped-flow spectroscopy was used to measure Ca2+ dissociation rate (koff) from whole cTn complexes containing recombinant wild type (WT) cTnI, cTnT and either ...
[51]
How is cardiac troponin released from cardiomyocytes? - PMC - NIH
Aug 16, 2022 · As the cTnI:cTnT complex binds tightly to the cardiac sarcomere, its release is dictated by local proteolysis, which separates cTnI from cTnT ( ...
[52]
Myocardial Injury and the Release of Troponins I and T in the Blood ...
Dec 12, 2020 · After the injury of cardiac cells, the troponin complex is released into the blood, accompanied by proteolysis of cTns and partial dissociation ...
[53]
Troponins in myocardial infarction and injury - Australian Prescriber
However, because of continued leaching of troponin from necrotic myocardium, the apparent half-life is of the order of 24 hours with cTnT slightly longer.Missing: window | Show results with:window
[54]
Fourth Universal Definition of Myocardial Infarction (2018) | Circulation
Aug 24, 2018 · Studies have shown that myocardial injury, defined by an elevated cardiac troponin (cTn) value, is frequently encountered clinically and is ...
[55]
Fourth Universal Definition of Myocardial Infarction
Aug 25, 2018 · Detection of an elevated cTn value above the 99th percentile upper reference limit (URL) is defined as myocardial injury.
[56]
Prognostic Value of High-Sensitivity Troponin T in Chronic ... - PubMed
Jan 16, 2018 · In chronic heart failure, high-sensitivity troponin T is a strong and independent predictor of all-cause and cardiovascular mortality, and of hospitalization.
[57]
Association of high-sensitivity troponin T with outcomes in ...
Feb 28, 2023 · In aortic valve stenosis (AS), cardiac troponins have been associated to AS progression, the need for aortic valve replacement surgery (AVR) and ...
[58]
Some Common Causes of False Positive Increases in Serum Levels ...
The study of skeletal muscle biopsy specimens showed no expression of cardiac troponin isoforms in them, leading the researchers to a conclusion that there is ...
[59]
Cardiac Troponin and the True False Positive∗ | JACC: Case Reports
Mar 18, 2020 · Cardiac causes of troponin elevation include heart failure, pulmonary embolism, Takotsubo cardiomyopathy, myocarditis, cardiomyopathies ...
[60]
The Main Causes and Mechanisms of Increase in Cardiac Troponin ...
Sep 21, 2021 · Pulmonary embolism (PE) is a frequent cause of troponin elevation. Approximately 50% of patients feel “coronary-like” pain, which leads to ...
[61]
Highly Sensitive Cardiac Troponins: The Evidence Behind Sex ...
May 9, 2020 · We posit that there may nonetheless be clinical value in the use of sex‐specific cutoffs for evaluating suspected acute coronary syndrome.
[62]
https://hytest.fi/news/anti-ctnt-mabs-with-negligible-cross-reactivity-to-skeletal-forms
[63]
Anti-cTnT MAbs with Negligible Cross-Reactivity to Skeletal ... - HyTest
May 30, 2018 · All three MAbs recognized only cTnT (see Figure 1). Second, we tested the cross-reactivity of the two prototype assays to purified native skTnT, ...
[64]
Profile of Roche's Elecsys Troponin T Gen 5 STAT blood test (a high ...
... Roche Diagnostics, Indianapolis, IN) is the first high-sensitivity cardiac troponin test approved for use by the FDA in the US (2017). Areas covered: The test ...
[65]
US6376206B1 - Specific antibodies to troponin T, their production ...
The invention concerns specific antibodies to cardiac muscle troponin T, their production and use in an immunological reagent for the determination of ...
[66]
Comparison of Point-of-Care and Highly Sensitive Laboratory ...
Feb 24, 2022 · This study aimed to compare the results of POC-cTnI testing with those of the gold standard, automated central laboratory testing of troponin (ie, hs-cTnI).
[67]
Recommendations for Institutions Transitioning to High-Sensitivity ...
Feb 21, 2019 · When determining whether there has been a rise or fall of troponin on serial sampling, absolute change in troponin concentration has greater ...
[68]
[PDF] Cardiac Troponin Assays: Guide to Understanding Analytical ...
Cardiac troponin testing has been the standard of practice for the diagnosis of acute myo- cardial infarction (AMI), early rule-out, risk stratifica- tion, and ...
[69]
High-Sensitivity Cardiac Troponin and the 2021 AHA/ACC/ASE ...
Because hs-cTn assays detect more chronic myocardial injury, the importance of differentiating between acute and chronic injury with serial sampling should be ...